Orthofix Medical Inc.
General ticker "OFIX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $532.5M (TTM average)
Orthofix Medical Inc. does not follow the US Stock Market performance with the rate: -13.1%.
Estimated limits based on current volatility of 3.3%: low 11.14$, high 11.79$
Factors to consider:
- Total employees count: 1605 (-0.7%) as of 2025
- US accounted for 84.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Regulatory and compliance, Supply chain disruptions, Product liability, Product development failure
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [9.42$, 18.10$]
- 2026-12-31 to 2027-12-31 estimated range: [9.09$, 17.53$]
Financial Metrics affecting the OFIX estimates:
- Positive: with PPE of 78.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Interest expense per share per price, % of 2.86 <= 3.34
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Positive: 42.57 < Shareholder equity ratio, % of 52.91 <= 64.23
- Positive: -0.03 < Operating cash flow per share per price, % of 5.45
- Negative: Industry earnings per price (median), % of -1.58 <= 0
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -15.17 <= -0.75
Short-term OFIX quotes
Long-term OFIX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $746.64MM | $799.49MM | $822.31MM |
| Operating Expenses | $885.75MM | $884.11MM | $890.78MM |
| Operating Income | $-139.11MM | $-84.62MM | $-68.47MM |
| Non-Operating Income | $-9.57MM | $-39.26MM | $-22.34MM |
| Interest Expense | $8.63MM | $29.63MM | $17.49MM |
| R&D Expense | $80.23MM | $73.64MM | $65.85MM |
| Income(Loss) | $-148.68MM | $-123.88MM | $-90.81MM |
| Taxes | $2.72MM | $2.12MM | $1.38MM |
| Net Income(Loss)* | $-151.40MM | $-126.00MM | $-92.19MM |
| Stockholders Equity | $598.73MM | $503.12MM | $450.04MM |
| Inventory | $222.17MM | $189.45MM | $34.17MM |
| Assets | $925.32MM | $893.29MM | $850.65MM |
| Operating Cash Flow | $-45.75MM | $25.79MM | $33.35MM |
| Capital expenditure | $62.05MM | $34.88MM | $34.63MM |
| Investing Cash Flow | $-33.13MM | $-27.58MM | $-34.60MM |
| Financing Cash Flow | $65.32MM | $50.71MM | $-0.79MM |
| Earnings Per Share** | $-4.12 | $-3.30 | $-2.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.